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Signals from unanchored chains
Cytosolic receptors, such as retinoic-acid-inducible gene-I 
(RIG-I), trigger signal transduction cascades that stimu-
late the immune system and result in the production of 
interferons and other molecules that suppress viral repli-
cation. Polyubiquitination, which has been implicated in 
a diverse array of signaling pathways, is important in the 
RIG-I pathway. Zeng and colleagues established a cell-
free system that mimics viral infection in intact cells. In 
this system, molecules that mimic viral DNA (5′-pppRNA 
and dsRNA) activated the entire RIG-I signaling cascade 
and subsequently activated the downstream transcrip-
tion factors NF-κB and IRF3. Importantly, incubation with 
RNA and unanchored K63-polyubiquitin (polyUb) chains 
induced activation of RIG-I and dimerization of IRF3. 
Specifically, the N-terminus of RIG-I, which contains tan-
dem caspase recruitment domains, binds to these polyUb 
chains (required for RIG-I activation). In addition, these 
polyUb chains activate RIG-I in human cells. Unanchored 
K63-polyUb chains are a novel and potent intracellular 
signaling molecule that activates the RIG-1 pathway. (Cell 
141:315–30, 2010)
Bone marrow replacement of collagen
Because current patient care for the inherited blister-
ing disease recessive dystrophic epidermolysis bullosa 
has been palliative and restricted to individual wounds, 
new treatment strategies for improving the quality of life 
in these patients are warranted. This disease is caused by 
loss-of-function mutations in the collagen type VII (C7) 
gene, and Wagner and colleagues performed a phase 
I–phase II clinical trial of bone marrow transplantation for 
collagen replacement in treating this disease. Infusion of 
unfiltered allogeneic bone marrow cells into six affected 
children partially corrected the C7 deficiency and result-
ed in improved skin and mucosal integrity. In agreement 
with previous reports, partial C7 correction was associated 
with clinical benefit. Interestingly, a substantial proportion 
of donor cells was detected in the skin and mucosa after 
treatment. This new treatment approach carries significant 
risk to the patient; the utility of such a treatment for a sys-
temic disease warrants follow-up. (N Engl J Med 363:629–
39, 2010)
Essential selenium
Antioxidant substances and enzymes often require trace 
elements such as dietary selenium to combat reactive 
oxygen species, which are implicated in skin disorders, 
including skin cancer. Selenium protects the skin and 
other organs via selenoproteins, which contain selenium 
in the form of selenocysteine (Sec). To examine the effects 
of selenoproteins in skin cells, the Sec tRNA, which gov-
erns the expression of all selenoproteins, was knocked out 
specifically in the epidermis of mice. These mice exhibited 
altered morphogenesis in the skin and hair follicles within 
days after birth and died prematurely. The results of this 
study revealed an essential protective role for selenium in 
the skin and provided evidence that deficiencies in sele-
noproteins result in the abnormalities observed in seleni-
um-deficient human skin. Taken together, these findings 
highlight the importance of selenoproteins in cutaneous 
function and development. (PLoS ONE 5:e12249, 2010)
Reversing muscle loss
In an attempt to understand the underlying mechanisms of 
cancer cachexia and muscle wasting, which account for 
nearly 30% of cancer-related deaths, Zhou and colleagues 
examined the effects of an antagonist of ActRIIB, a high-
affinity activin type 2 receptor with ligands that have been 
implicated in regulating muscle mass. This antagonist not 
only prevented further muscle wasting in mouse cancer 
models but also actually fully reversed skeletal muscle loss 
and heart atrophy without any concomitant effects on tumor 
growth, fat levels, or inflammatory cytokine expression. 
Functionally, these effects resulted in a prolonged survival 
of tumor-bearing animals. Administration of the antagonist 
blocked the ubiquitin–proteasome system and stimulated 
muscle satellite cell growth. Ultimately, development of 
antiactivin therapies may enhance the quality and length of 
life of cancer patients and may combat muscle loss under 
other catabolic conditions. (Cell 142:531–43, 2010)
Speedy delivery
Transepidermal drug delivery (TDD) has been used for 
addiction treatment, although current mechanisms for TDD 
cannot provide variable drug delivery rates, which are 
critical for successful drug withdrawal treatment. Wu and 
colleagues employed carbon nanotube (CNT) membranes, 
which allow highly efficient electrophoretic pumping, to 
control the delivery rates of nicotine in a programmable 
smoking cessation treatment device. Examination of these 
CNT membranes showed the membrane to be the rate-
limiting component and the flux values to be based on 
simple diffusion. Importantly, a common watch battery was 
sufficient to power the CNT membrane for 12 days. The 
steady-state flux of nicotine was sufficient for a therapeutic 
smoking cessation treatment device. These programmable 
TDD devices, which can be adapted for the delivery of 
various agents and which caused minimal skin irritation, 
will improve the delivery of drugs used in substance abuse 
treatment programs. (PNAS 107:11698–702, 2010)
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